Drug Screening Market (2025 - 2030) Size, Share & Trends Analysis Report By Product Type (Instruments, Consumables), By Sample Type (Urine Sample, Breath Sample), By End-use (Drug Treatment Centers), By Region, And Segment Forecasts

Table of Contents

Chapter 1. Methodology and Scope
                   1.1. Market Segmentation & Scope
                   1.2. Segment Definitions
                       1.2.1. Product Type
                       1.2.2. Sample Type
                       1.2.3. End Use
                   1.3. Research Methodology
                   1.4. Information Procurement
                       1.4.1. Purchased Database
                       1.4.2. GVR’s Internal Database
                       1.4.3. Secondary Sources
                       1.4.4. Primary Research
                   1.5. Information or Data Analysis
                       1.5.1. Data Analysis Models
                   1.6. Market Formulation & Validation
                   1.7. Model Details
                   1.8. List of Secondary Sources
                   1.9. Objectives
Chapter 2. Executive Summary
                   2.1. Market Outlook
                   2.2. Segment Outlook
                       2.2.1. Product Type Outlook
                       2.2.2. Sample Type Outlook
                       2.2.3. End Use Outlook
                       2.2.4. Regional Outlook
                   2.3. Competitive Insights
Chapter 3. Global Drug Screening Market Variables, Trends, & Scope
                   3.1. Market Lineage Outlook
                       3.1.1. Parent Market Outlook
                       3.1.2. Related/Ancillary Market Outlook
                   3.2. Market Dynamics
                       3.2.1. Market Driver Analysis
                       3.2.2. Market Restraint Analysis
                   3.3. Global Drug Screening Market Analysis Tools
                       3.3.1. Industry Analysis - Porter’s Five Forces Analysis
                           3.3.1.1. Supplier Power
                           3.3.1.2. Buyer Power
                           3.3.1.3. Substitution Threat
                           3.3.1.4. Threat of New Entrants
                           3.3.1.5. Competitive Rivalry
                       3.3.2. PESTLE Analysis
                           3.3.2.1. Political Landscape
                           3.3.2.2. Technological Landscape
                           3.3.2.3. Economic Landscape
Chapter 4. Global Drug Screening Market: Product Type Business Analysis
                   4.1. Product Type Segment Dashboard
                   4.2. Drug Screening Market: Product Type Movement Analysis
                   4.3. Global Drug Screening Market Size & Trend Analysis, By Product Type, 2018 to 2030 (USD Million)
                   4.4. Instruments
                       4.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
                       4.4.2. Immunoassays Analyzers
                           4.4.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
                       4.4.3. Chromatography Instruments
                           4.4.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
                       4.4.4. Breath Analyzer
                           4.4.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
                           4.4.4.2. Fuel Cell Breath Analyzer
                               4.4.4.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
                           4.4.4.3. Semi-Conductor Breath Analyzer
                               4.4.4.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
                           4.4.4.4. Others Breath Analyzer
                               4.4.4.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
                   4.5. Rapid Testing Devices
                       4.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
                       4.5.2. Urine Testing Devices
                           4.5.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
                           4.5.2.2. Drug Testing Cups
                               4.5.2.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
                           4.5.2.3. Dip Cards
                               4.5.2.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
                           4.5.2.4. Drug Testing Cassettes
                               4.5.2.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
                       4.5.3. Oral Fluid Testing Devices
                       4.5.4. Market Estimates and Forecasts 2018 to 2030 (USD Million)
                   4.6. Consumables
                       4.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
                       4.6.2. Assay Kits
                           4.6.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
                       4.6.3. Sample Collection Devices
                           4.6.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
                       4.6.4. Calibrators & Controls
                           4.6.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
                       4.6.5. Other Consumables
                           4.6.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
                   4.7. Services & Others
                       4.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
Chapter 5. Global Drug Screening Market: Sample Type Business Analysis
                   5.1. Sample Type Segment Dashboard
                   5.2. Drug Screening Market: Sample Type Movement Analysis
                   5.3. Global Drug Screening Market Size & Trend Analysis, By Sample Type, 2018 to 2030 (USD Million)
                   5.4. Urine Samples
                       5.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
                   5.5. Breath Samples
                       5.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
                   5.6. Oral Fluid Samples
                       5.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
                   5.7. Hair Samples
                       5.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
                   5.8. Other Samples
                       5.8.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
Chapter 6. Global Drug Screening Market: End Use Business Analysis
                   6.1. End Use Segment Dashboard
                   6.2. Drug Screening Market: End Use Movement Analysis
                   6.3. Global Drug Screening Market Size & Trend Analysis, By End Use, 2018 to 2030 (USD Million)
                   6.4. Hospitals
                       6.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
                   6.5. Criminal Justice & Law Enforcement Agencies
                       6.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
                   6.6. Workplaces
                       6.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
                   6.7. Drug Treatment Centers
                       6.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
                   6.8. Individual Users
                       6.8.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
                   6.9. Pain Management Centers
                       6.9.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
                   6.10. Schools & Colleges
                       6.10.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
                   6.11. Others
                       6.11.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
Chapter 7. Global Drug Screening Market: Regional Estimates & Trend Analysis
                   7.1. Regional Market Dashboard
                   7.2. Regional Market Share Analysis, 2024 & 2030
                   7.3. Global Drug Screening Market by Regional: Key Takeaways
                   7.4. North America
                       7.4.1. U.S.
                           7.4.1.1. Key Country Dynamics
                           7.4.1.2. Regulatory Framework/ Reimbursement Structure
                           7.4.1.3. Competitive Scenario
                           7.4.1.4. U.S. Market Estimates and Forecasts 2018 to 2030 (USD Million)
                       7.4.2. Canada
                           7.4.2.1. Key Country Dynamics
                           7.4.2.2. Regulatory Framework/ Reimbursement Structure
                           7.4.2.3. Competitive Scenario
                           7.4.2.4. Canada Market Estimates and Forecasts 2018 to 2030 (USD Million)
                       7.4.3. Mexico
                           7.4.3.1. Key Country Dynamics
                           7.4.3.2. Regulatory Framework/ Reimbursement Structure
                           7.4.3.3. Competitive Scenario
                           7.4.3.4. Mexico Market Estimates and Forecasts 2018 to 2030 (USD Million)
                   7.5. Europe
                       7.5.1. Germany
                           7.5.1.1. Key Country Dynamics
                           7.5.1.2. Regulatory Framework/ Reimbursement Structure
                           7.5.1.3. Competitive Scenario
                           7.5.1.4. Germany Market Estimates and Forecasts 2018 to 2030 (USD Million)
                       7.5.2. UK
                           7.5.2.1. Key Country Dynamics
                           7.5.2.2. Regulatory Framework/ Reimbursement Structure
                           7.5.2.3. Competitive Scenario
                           7.5.2.4. UK Market Estimates and Forecasts 2018 to 2030 (USD Million)
                       7.5.3. France
                           7.5.3.1. Key Country Dynamics
                           7.5.3.2. Regulatory Framework/ Reimbursement Structure
                           7.5.3.3. Competitive Scenario
                           7.5.3.4. France Market Estimates and Forecasts 2018 to 2030 (USD Million)
                       7.5.4. Italy
                           7.5.4.1. Key Country Dynamics
                           7.5.4.2. Regulatory Framework/ Reimbursement Structure
                           7.5.4.3. Competitive Scenario
                           7.5.4.4. Italy Market Estimates and Forecasts 2018 to 2030 (USD Million)
                       7.5.5. Spain
                           7.5.5.1. Key Country Dynamics
                           7.5.5.2. Regulatory Framework/ Reimbursement Structure
                           7.5.5.3. Competitive Scenario
                           7.5.5.4. Spain Market Estimates and Forecasts 2018 to 2030 (USD Million)
                       7.5.6. Denmark
                           7.5.6.1. Key Country Dynamics
                           7.5.6.2. Regulatory Framework/ Reimbursement Structure
                           7.5.6.3. Competitive Scenario
                           7.5.6.4. Denmark Market Estimates and Forecasts 2018 to 2030 (USD Million)
                       7.5.7. Sweden
                           7.5.7.1. Key Country Dynamics
                           7.5.7.2. Regulatory Framework/ Reimbursement Structure
                           7.5.7.3. Competitive Scenario
                           7.5.7.4. Sweden Market Estimates and Forecasts 2018 to 2030 (USD Million)
                       7.5.8. Norway
                           7.5.8.1. Key Country Dynamics
                           7.5.8.2. Regulatory Framework/ Reimbursement Structure
                           7.5.8.3. Competitive Scenario
                           7.5.8.4. Norway Market Estimates and Forecasts 2018 to 2030 (USD Million)
                   7.6. Asia Pacific
                       7.6.1. Japan
                           7.6.1.1. Key Country Dynamics
                           7.6.1.2. Regulatory Framework/ Reimbursement Structure
                           7.6.1.3. Competitive Scenario
                           7.6.1.4. Japan Market Estimates and Forecasts 2018 to 2030 (USD Million)
                       7.6.2. China
                           7.6.2.1. Key Country Dynamics
                           7.6.2.2. Regulatory Framework/ Reimbursement Structure
                           7.6.2.3. Competitive Scenario
                           7.6.2.4. China Market Estimates and Forecasts 2018 to 2030 (USD Million)
                       7.6.3. India
                           7.6.3.1. Key Country Dynamics
                           7.6.3.2. Regulatory Framework/ Reimbursement Structure
                           7.6.3.3. Competitive Scenario
                           7.6.3.4. India Market Estimates and Forecasts 2018 to 2030 (USD Million)
                       7.6.4. Australia
                           7.6.4.1. Key Country Dynamics
                           7.6.4.2. Regulatory Framework/ Reimbursement Structure
                           7.6.4.3. Competitive Scenario
                           7.6.4.4. Australia Market Estimates and Forecasts 2018 to 2030 (USD Million)
                       7.6.5. Thailand
                           7.6.5.1. Key Country Dynamics
                           7.6.5.2. Regulatory Framework/ Reimbursement Structure
                           7.6.5.3. Competitive Scenario
                           7.6.5.4. Thailand Market Estimates and Forecasts 2018 to 2030 (USD Million)
                       7.6.6. South Korea
                           7.6.6.1. Key Country Dynamics
                           7.6.6.2. Regulatory Framework/ Reimbursement Structure
                           7.6.6.3. Competitive Scenario
                           7.6.6.4. South Korea Market Estimates and Forecasts 2018 to 2030 (USD Million)
                   7.7. Latin America
                       7.7.1. Brazil
                           7.7.1.1. Key Country Dynamics
                           7.7.1.2. Regulatory Framework/ Reimbursement Structure
                           7.7.1.3. Competitive Scenario
                           7.7.1.4. Brazil Market Estimates and Forecasts 2018 to 2030 (USD Million)
                       7.7.2. Argentina
                           7.7.2.1. Key Country Dynamics
                           7.7.2.2. Regulatory Framework/ Reimbursement Structure
                           7.7.2.3. Competitive Scenario
                           7.7.2.4. Argentina Market Estimates and Forecasts 2018 to 2030 (USD Million)
                   7.8. Middle East & Africa
                       7.8.1. South Africa
                           7.8.1.1. Key Country Dynamics
                           7.8.1.2. Regulatory Framework/ Reimbursement Structure
                           7.8.1.3. Competitive Scenario
                           7.8.1.4. South Africa Market Estimates and Forecasts 2018 to 2030 (USD Million)
                       7.8.2. Saudi Arabia
                           7.8.2.1. Key Country Dynamics
                           7.8.2.2. Regulatory Framework/ Reimbursement Structure
                           7.8.2.3. Competitive Scenario
                           7.8.2.4. South Arabia Market Estimates and Forecasts 2018 to 2030 (USD Million)
                       7.8.3. UAE
                           7.8.3.1. Key Country Dynamics
                           7.8.3.2. Regulatory Framework/ Reimbursement Structure
                           7.8.3.3. Competitive Scenario
                           7.8.3.4. UAE Market Estimates and Forecasts 2018 to 2030 (USD Million)
                       7.8.4. Kuwait
                           7.8.4.1. Key Country Dynamics
                           7.8.4.2. Regulatory Framework/ Reimbursement Structure
                           7.8.4.3. Competitive Scenario
                           7.8.4.4. Kuwait Market Estimates and Forecasts 2018 to 2030 (USD Million)
Chapter 8. Competitive Landscape
                   8.1. Recent Developments & Impact Analysis, By Key Market Participants
                   8.2. Company/Competition Categorization
                   8.3. Vendor Landscape
                       8.3.1. Key Company Heat Map Analysis, 2024
                   8.4. Company Profiles
                       8.4.1. Abbott
                           8.4.1.1. Company Overview
                           8.4.1.2. Financial Performance
                           8.4.1.3. Product Benchmarking
                           8.4.1.4. Strategic Initiatives
                       8.4.2. Quest Diagnostics Incorporated
                           8.4.2.1. Company Overview
                           8.4.2.2. Financial Performance
                           8.4.2.3. Product Benchmarking
                           8.4.2.4. Strategic Initiatives
                       8.4.3. F. Hoffmann-La Roche Ltd
                           8.4.3.1. Company Overview
                           8.4.3.2. Financial Performance
                           8.4.3.3. Product Benchmarking
                           8.4.3.4. Strategic Initiatives
                       8.4.4. Thermo Fisher Scientific Inc.
                           8.4.4.1. Company Overview
                           8.4.4.2. Financial Performance
                           8.4.4.3. Product Benchmarking
                           8.4.4.4. Strategic Initiatives
                       8.4.5. Siemens Healthcare AG
                           8.4.5.1. Company Overview
                           8.4.5.2. Financial Performance
                           8.4.5.3. Product Benchmarking
                           8.4.5.4. Strategic Initiatives
                       8.4.6. Laboratory Corporation of America Holdings
                           8.4.6.1. Company Overview
                           8.4.6.2. Financial Performance
                           8.4.6.3. Product Benchmarking
                           8.4.6.4. Strategic Initiatives
                       8.4.7. Alfa Scientific Designs, Inc.
                           8.4.7.1. Company Overview
                           8.4.7.2. Financial Performance
                           8.4.7.3. Product Benchmarking
                           8.4.7.4. Strategic Initiatives
                       8.4.8. OraSure Technologies, Inc.
                           8.4.8.1. Company Overview
                           8.4.8.2. Financial Performance
                           8.4.8.3. Product Benchmarking
                           8.4.8.4. Strategic Initiatives
                       8.4.9. Omega Laboratories, Inc.
                           8.4.9.1. Company Overview
                           8.4.9.2. Financial Performance
                           8.4.9.3. Product Benchmarking
                           8.4.9.4. Strategic Initiatives
                       8.4.10. Drägerwerk AG & Co. KGaA
                           8.4.10.1. Company Overview
                           8.4.10.2. Financial Performance
                           8.4.10.3. Product Benchmarking
                           8.4.10.4. Strategic Initiatives
                       8.4.11. Bio-Rad Laboratories, Inc.
                           8.4.11.1. Company Overview
                           8.4.11.2. Financial Performance
                           8.4.11.3. Product Benchmarking
                           8.4.11.4. Strategic Initiatives

List of Tables

Table 1. List Of Abbreviations
Table 2. Global Drug Screening Market, By Product Type, 2018 - 2030 (USD Million)
Table 3. Global Drug Screening Market, By Sample Type, 2018 - 2030 (USD Million)
Table 4. Global Drug Screening Market, By End Use, 2018 - 2030 (USD Million)
Table 5. Global Drug Screening Market, By Region, 2018 - 2030 (USD Million)
Table 6. North America Drug Screening Market, By Country, 2018 - 2030 (USD Million)
Table 7. North America Drug Screening Market, By Product Type, 2018 - 2030 (USD Million)
Table 8. North America Drug Screening Market, By Sample Type, 2018 - 2030 (USD Million)
Table 9. North America Drug Screening Market, By End Use, 2018 - 2030 (USD Million)
Table 10. U.S. Drug Screening Market, By Product Type, 2018 - 2030 (USD Million)
Table 11. U.S. Drug Screening Market, By Sample Type, 2018 - 2030 (USD Million)
Table 12. U.S. Drug Screening Market, By End Use, 2018 - 2030 (USD Million)
Table 13. Canada Drug Screening Market, By Product Type, 2018 - 2030 (USD Million)
Table 14. Canada Drug Screening Market, By Sample Type, 2018 - 2030 (USD Million)
Table 15. Canada Drug Screening Market, By End Use, 2018 - 2030 (USD Million)
Table 16. Mexico Drug Screening Market, By Product Type, 2018 - 2030 (USD Million)
Table 17. Mexico Drug Screening Market, By Sample Type, 2018 - 2030 (USD Million)
Table 18. Mexico Drug Screening Market, By End Use, 2018 - 2030 (USD Million)
Table 19. Europe Drug Screening Market, By Country, 2018 - 2030 (USD Million)
Table 20. Europe Drug Screening Market, By Product Type, 2018 - 2030 (USD Million)
Table 21. Europe Drug Screening Market, By Sample Type, 2018 - 2030 (USD Million)
Table 22. Europe Drug Screening Market, By End Use, 2018 - 2030 (USD Million)
Table 23. Germany Drug Screening Market, By Product Type, 2018 - 2030 (USD Million)
Table 24. Germany Drug Screening Market, By Sample Type, 2018 - 2030 (USD Million)
Table 25. Germany Drug Screening Market, By End Use, 2018 - 2030 (USD Million)
Table 26. UK Drug Screening Market, By Product Type, 2018 - 2030 (USD Million)
Table 27. UK Drug Screening Market, By Sample Type, 2018 - 2030 (USD Million)
Table 28. UK Drug Screening Market, By End Use, 2018 - 2030 (USD Million)
Table 29. France Drug Screening Market, By Product Type, 2018 - 2030 (USD Million)
Table 30. France Drug Screening Market, By Sample Type, 2018 - 2030 (USD Million)
Table 31. France Drug Screening Market, By End Use, 2018 - 2030 (USD Million)
Table 32. Italy Drug Screening Market, By Product Type, 2018 - 2030 (USD Million)
Table 33. Italy Drug Screening Market, By Sample Type, 2018 - 2030 (USD Million)
Table 34. Italy Drug Screening Market, By End Use, 2018 - 2030 (USD Million)
Table 35. Spain Drug Screening Market, By Product Type, 2018 - 2030 (USD Million)
Table 36. Spain Drug Screening Market, By Sample Type, 2018 - 2030 (USD Million)
Table 37. Spain Drug Screening Market, By End Use, 2018 - 2030 (USD Million)
Table 38. Denmark Drug Screening Market, By Product Type, 2018 - 2030 (USD Million)
Table 39. Denmark Drug Screening Market, By Sample Type, 2018 - 2030 (USD Million)
Table 40. Denmark Drug Screening Market, By End Use, 2018 - 2030 (USD Million)
Table 41. Sweden Drug Screening Market, By Product Type, 2018 - 2030 (USD Million)
Table 42. Sweden Drug Screening Market, By Sample Type, 2018 - 2030 (USD Million)
Table 43. Sweden Drug Screening Market, By End Use, 2018 - 2030 (USD Million)
Table 44. Norway Drug Screening Market, By Product Type, 2018 - 2030 (USD Million)
Table 45. Norway Drug Screening Market, By Sample Type, 2018 - 2030 (USD Million)
Table 46. Norway Drug Screening Market, By End Use, 2018 - 2030 (USD Million)
Table 47. Asia Pacific Drug Screening Market, By Country, 2018 - 2030 (USD Million)
Table 48. Asia Pacific Drug Screening Market, By Product Type, 2018 - 2030 (USD Million)
Table 49. Asia Pacific Drug Screening Market, By Sample Type, 2018 - 2030 (USD Million)
Table 50. Asia Pacific Drug Screening Market, By End Use, 2018 - 2030 (USD Million)
Table 51. China Drug Screening Market, By Product Type, 2018 - 2030 (USD Million)
Table 52. China Drug Screening Market, By Sample Type, 2018 - 2030 (USD Million)
Table 53. China Drug Screening Market, By End Use, 2018 - 2030 (USD Million)
Table 54. Japan Drug Screening Market, By Product Type, 2018 - 2030 (USD Million)
Table 55. Japan Drug Screening Market, By Sample Type, 2018 - 2030 (USD Million)
Table 56. Japan Drug Screening Market, By End Use, 2018 - 2030 (USD Million)
Table 57. India Drug Screening Market, By Product Type, 2018 - 2030 (USD Million)
Table 58. India Drug Screening Market, By Sample Type, 2018 - 2030 (USD Million)
Table 59. India Drug Screening Market, By End Use, 2018 - 2030 (USD Million)
Table 60. South Korea Drug Screening Market, By Product Type, 2018 - 2030 (USD Million)
Table 61. South Korea Drug Screening Market, By Sample Type, 2018 - 2030 (USD Million)
Table 62. South Korea Drug Screening Market, By End Use, 2018 - 2030 (USD Million)
Table 63. Australia Drug Screening Market, By Product Type, 2018 - 2030 (USD Million)
Table 64. Australia Drug Screening Market, By Sample Type, 2018 - 2030 (USD Million)
Table 65. Australia Drug Screening Market, By End Use, 2018 - 2030 (USD Million)
Table 66. Thailand Drug Screening Market, By Product Type, 2018 - 2030 (USD Million)
Table 67. Thailand Drug Screening Market, By Sample Type, 2018 - 2030 (USD Million)
Table 68. Thailand Drug Screening Market, By End Use, 2018 - 2030 (USD Million)
Table 69. Latin America Drug Screening Market, By Country, 2018 - 2030 (USD Million)
Table 70. Latin America Drug Screening Market, By Product Type, 2018 - 2030 (USD Million)
Table 71. Latin America Drug Screening Market, By Sample Type, 2018 - 2030 (USD Million)
Table 72. Latin America Drug Screening Market, By End Use, 2018 - 2030 (USD Million)
Table 73. Brazil Drug Screening Market, By Product Type, 2018 - 2030 (USD Million)
Table 74. Brazil Drug Screening Market, By Sample Type, 2018 - 2030 (USD Million)
Table 75. Argentina Drug Screening Market, By Product Type, 2018 - 2030 (USD Million)
Table 76. Argentina Drug Screening Market, By Sample Type, 2018 - 2030 (USD Million)
Table 77. Argentina Drug Screening Market, By End Use, 2018 - 2030 (USD Million)
Table 78. MEA Drug Screening Market, By Region, 2018 - 2030 (USD Million)
Table 79. MEA Drug Screening Market, By Product Type, 2018 - 2030 (USD Million)
Table 80. MEA Drug Screening Market, By Sample Type, 2018 - 2030 (USD Million)
Table 81. MEA Drug Screening Market, By End Use, 2018 - 2030 (USD Million)
Table 82. South Africa Drug Screening Market, By Product Type, 2018 - 2030 (USD Million)
Table 83. South Africa Drug Screening Market, By Sample Type, 2018 - 2030 (USD Million)
Table 84. South Africa Drug Screening Market, By End Use, 2018 - 2030 (USD Million)
Table 85. Saudi Arabia Drug Screening Market, By Product Type, 2018 - 2030 (USD Million)
Table 86. Saudi Arabia Drug Screening Market, By Sample Type, 2018 - 2030 (USD Million)
Table 87. Saudi Arabia Drug Screening Market, By End Use, 2018 - 2030 (USD Million)
Table 88. UAE Drug Screening Market, By Product Type, 2018 - 2030 (USD Million)
Table 89. UAE Drug Screening Market, By Sample Type, 2018 - 2030 (USD Million)
Table 90. UAE Drug Screening Market, By End Use, 2018 - 2030 (USD Million)
Table 91. Kuwait Drug Screening Market, By Product Type, 2018 - 2030 (USD Million)
Table 92. Kuwait Drug Screening Market, By Sample Type, 2018 - 2030 (USD Million)
Table 93. Kuwait Drug Screening Market, By End Use, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Market Research Process
Fig. 2 Data Triangulation Sample Types
Fig. 3 Primary Research Pattern
Fig. 4 Primary Interviews
Fig. 5 Market Research Approaches
Fig. 6 Value-Chain-Based Sizing & Forecasting
Fig. 7 QFD Modeling for Market Share Assessment
Fig. 8 Market Formulation & Validation
Fig. 9 Drug Screening Market: Market Outlook
Fig. 10 Drug Screening Competitive Insights
Fig. 11 Parent Market Outlook
Fig. 12 Related/Ancillary Market Outlook
Fig. 13 Penetration and Growth Prospect Mapping
Fig. 14 Industry Value Chain Analysis
Fig. 15 Drug Screening Market Driver Impact
Fig. 16 Drug Screening Market Restraint Impact
Fig. 17 Drug Screening Market Strategic Initiatives Analysis
Fig. 18 Drug Screening Market: Product Type Movement Analysis
Fig. 19 Drug Screening Market: Product Type Outlook and Key Takeaways
Fig. 20 Instruments Market Estimates and Forecast, 2018 - 2030
Fig. 21 Rapid Testing Devices Market Estimates and Forecast, 2018 - 2030
Fig. 22 Consumables Market Estimates and Forecast, 2018 - 2030
Fig. 23 Services & Others Market Estimates and Forecast, 2018 - 2030
Fig. 24 Drug Screening Market: Sample Type Movement Analysis
Fig. 25 Drug Screening Market: Sample Type Outlook and Key Takeaways
Fig. 26 Urine Samples Market Estimates and Forecast, 2018 - 2030
Fig. 27 Breath Samples Market Estimates and Forecast, 2018 - 2030
Fig. 28 Oral Fluid Samples Market Estimates and Forecast, 2018 - 2030
Fig. 29 Hair Samples Market Estimates and Forecast, 2018 - 2030
Fig. 30 Other Samples Market Estimates and Forecast, 2018 - 2030
Fig. 31 Drug Screening Market: End Use Movement Analysis
Fig. 32 Drug Screening Market: End Use Outlook and Key Takeaways
Fig. 33 Hospitals Market Estimates and Forecasts, 2018 - 2030
Fig. 34 Criminal Justice & Law Enforcement Agencies Market Estimates and Forecasts, 2018 - 2030
Fig. 35 Workplaces Market Estimates and Forecasts, 2018 - 2030
Fig. 36 Drug Treatment Centers Market Estimates and Forecasts, 2018 - 2030
Fig. 37 Individual Users Market Estimates and Forecasts, 2018 - 2030
Fig. 38 Pain Management Centers Market Estimates and Forecasts, 2018 - 2030
Fig. 39 Schools & Colleges Market Estimates and Forecasts, 2018 - 2030
Fig. 40 Others Market Estimates and Forecasts, 2018 - 2030
Fig. 41 Global Drug Screening Market: Regional Movement Analysis
Fig. 42 Global Drug Screening Market: Regional Outlook and Key Takeaways
Fig. 43 North America Market Estimates and Forecasts, 2018 - 2030
Fig. 44 U.S. Market Estimates and Forecasts, 2018 - 2030
Fig. 45 Canada Market Estimates and Forecasts, 2018 - 2030
Fig. 46 Mexico Market Estimates and Forecasts, 2018 - 2030
Fig. 47 Europe Market Estimates and Forecasts, 2018 - 2030
Fig. 48 UK Market Estimates and Forecasts, 2018 - 2030
Fig. 49 Germany Market Estimates and Forecasts, 2018 - 2030
Fig. 50 France Market Estimates and Forecasts, 2018 - 2030
Fig. 51 Italy Market Estimates and Forecasts, 2018 - 2030
Fig. 52 Spain Market Estimates and Forecasts, 2018 - 2030
Fig. 53 Denmark Market Estimates and Forecasts, 2018 - 2030
Fig. 54 Sweden Market Estimates and Forecasts, 2018 - 2030
Fig. 55 Norway Market Estimates and Forecasts, 2018 - 2030
Fig. 56 Asia Pacific Market Estimates and Forecasts, 2018 - 2030
Fig. 57 China Market Estimates and Forecasts, 2018 - 2030
Fig. 58 Japan Market Estimates and Forecasts, 2018 - 2030
Fig. 59 India Market Estimates and Forecasts, 2018 - 2030
Fig. 60 Thailand Market Estimates and Forecasts, 2018 - 2030
Fig. 61 South Korea Market Estimates and Forecasts, 2018 - 2030
Fig. 62 Australia Market Estimates and Forecasts, 2018 - 2030
Fig. 63 Latin America Market Estimates and Forecasts, 2018 - 2030
Fig. 64 Brazil Market Estimates and Forecasts, 2018 - 2030
Fig. 65 Argentina Market Estimates and Forecasts, 2018 - 2030
Fig. 66 Middle East and Africa Market Estimates and Forecasts, 2018 - 2030
Fig. 67 South Africa Market Estimates and Forecasts, 2018 - 2030
Fig. 68 Saudi Arabia Market Estimates and Forecasts, 2018 - 2030
Fig. 69 UAE Market Estimates and Forecasts, 2018 - 2030
Fig. 70 Kuwait Market Estimates and Forecasts, 2018 - 2030